AQR Capital Management LLC Has $22.60 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

AQR Capital Management LLC raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 245,885 shares of the medical device company's stock after buying an additional 9,894 shares during the period. AQR Capital Management LLC owned about 0.12% of Cooper Companies worth $22,604,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of COO. Byrne Asset Management LLC acquired a new stake in shares of Cooper Companies in the 4th quarter valued at about $33,000. OFI Invest Asset Management acquired a new stake in Cooper Companies during the fourth quarter valued at approximately $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies during the 4th quarter worth approximately $38,000. Covestor Ltd increased its holdings in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after acquiring an additional 120 shares during the last quarter. Finally, West Financial Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter valued at approximately $49,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the stock. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Price Performance

Shares of COO traded down $0.16 during midday trading on Friday, reaching $82.76. The stock had a trading volume of 428,104 shares, compared to its average volume of 1,440,154. The firm's 50 day moving average price is $80.71 and its 200-day moving average price is $91.19. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The company has a market capitalization of $16.55 billion, a P/E ratio of 42.44, a P/E/G ratio of 2.25 and a beta of 1.08. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. On average, analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.